A Study of [¹⁴C]-LY3484356 in Healthy Female Participants

NCT04991766 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: [¹⁴C]-LY3484356
DRUG: LY3484356
DRUG: [¹⁴C]-LY3484356 (IV)

Sponsor

Eli Lilly and Company